Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001230625 | SCV001403109 | likely benign | Tuberous sclerosis 1 | 2024-06-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002436895 | SCV002746274 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-05-03 | criteria provided, single submitter | clinical testing | The p.P372A variant (also known as c.1114C>G), located in coding exon 9 of the TSC1 gene, results from a C to G substitution at nucleotide position 1114. The proline at codon 372 is replaced by alanine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002504308 | SCV002806222 | uncertain significance | Lymphangiomyomatosis; Tuberous sclerosis 1; Isolated focal cortical dysplasia type II | 2021-12-09 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004004835 | SCV004840484 | uncertain significance | Tuberous sclerosis syndrome | 2024-01-11 | criteria provided, single submitter | clinical testing | This missense variant replaces proline with alanine at codon 372 of the TSC1 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with hereditary cancer in the literature. This variant has been identified in 1/31390 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |